Loading...
Genmab A/S
GMAB•NASDAQ
Healthcare
Biotechnology
$26.60
$0.05(0.19%)
U.S. Market is Open • 15:44GMAB News Today: Stay Updated with the Latest Genmab A/S News in Real Time
Find GMAB news now at Meyka AI. Stay informed with the latest Genmab A/S stocks updates, including price news, market analysis, and expert insights.
📅 3 days ago
GMAB Maintained at Buy by Deutsche Bank, May 2026
Deutsche Bank maintains GMAB at Buy rating with price target lowered to DKK 2,250 from DKK 2,400.
Read more
📅 9 days ago
GMAB Earnings Preview: Genmab Q1 2026 on May 7
Genmab (GMAB) reports Q1 2026 earnings May 7. Analysts expect $0.15 EPS, $905.77M revenue. Stock at $27.52.
Read more
📅 2 months ago
BNTX Stock Today: Founders to Exit; PT Cut to $167 – March 12
BNTX stock today: founders to exit by 2026 and Clear Street cuts price target to $167. What this means for leadership, IP, valuation, mRNA pipeline, and key trading levels for German investors.
Read more
📅 8 months ago
BNTX News Today: BioNTech Stock Rises Sharply on Promising mRNA Flu-V3
BioNTech shares surge with promising interim results from its mRNA-based flu vaccine trial, signaling potential beyond COVID-19.
Read more